ArticleFrontiers in artificial intelligence2025
Enhanced deep Convolutional Neural Network for SARS-CoV-2 variants classification.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Machine learning-driven decision support for antibiotic optimization in typhoid fever based on patient profiles.BMC medical informatics and decision making · 2026Article
- rhinotypeR enables reproducible rhinovirus genotype assignment from VP4/2 sequences.Scientific reports · 2026Article
- MARVpred: machine learning prediction of inhibitors targeting Marburg virus Gene 4 Small ORF protein.BMC infectious diseases · 2026Article
- RareInsight simplifies the communication of genetic results for rare disease patients.Scientific reports · 2025Article
- Efficient and easy gene expression and genetic variation data analysis and visualization using exvar.Scientific reports · 2025Article
- TargetingFrontiers in bioinformatics · 2025Article
- Prostruc: an open-source tool for 3D structure prediction using homology modeling.Frontiers in chemistry · 2024Article
- Machine learning and molecular dynamics simulations predict potential TGR5 agonists for type 2 diabetes treatment.Frontiers in chemistry · 2024Article
- Machine learning and molecular docking prediction of potential inhibitors against dengue virus.Frontiers in chemistry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Rapid and scalable classification of SARS-CoV-2 genomes from spike-gene sequences can support real-time genomic surveillance in contexts where whole-genome data or high-end computing resources are limited. Methods: We curated approximately 35,800 quality-filtered spike sequences spanning multiple clades and lineages and trained a hybrid CNN-BiLSTM model with standard regularization and class-imbalance handling. Model performance was benchmarked against Nextclade assignments and compared with classical machine-learning baselines. Results: Across 10 experimental runs, the model achieved a mean training accuracy of 99.74% ± 0.11, a validation accuracy of 99.00% ± 0.00, and a test accuracy of 99.91% ± 0.03. In benchmarking against the molecular epidemiology tool Nextclade, our model demonstrated superior performance, correctly identifying 100% of Omicron sequences, compared to 34.95% achieved by Nextclade. Saliency and feature attribution analyses highlighted recurrent spike substitutions consistent with known variant-defining mutations, as well as additional uncharacterized motifs with potential biological relevance. Discussion: These findings demonstrate that spike-only deep models can provide rapid and accurate clade or variant classification, while also yielding interpretable feature importance. Such models complement phylogenetic approaches in settings with constrained resources and enable efficient triage of samples for confirmatory whole-genome analysis, supporting more timely genomic surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.